• PCIF1 suppresses glioblastoma cell migration and invasion by inhibiting EMT.
• PCIF1 modulates AKT signaling via proteasomal degradation and phosphorylation.
• PCIF1 regulates phosphoinositide levels through INPP5B, affecting PI(3,4)P2 and PI(3,4,5)P3.
• PCIF1 is a potential biomarker and therapeutic target for glioblastoma.